Neil Desai, Executive Chairman at Aadi Bioscience, Inc. (AADI), sold 64,498 shares at $8.11 ($519K) on 2023-06-05, disclosed to the SEC on 2023-06-05.
Open-market sale of $519k AADI by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.92 | 4,982 | $39K | 7.6% |
| 2 | $7.99 | 12,443 | $99K | 19.2% |
| 3 | $7.99 | 12,443 | $99K | 19.2% |
| 4 | $8.11 | 17,315 | $140K | 27.0% |
| 5 | $8.11 | 17,315 | $140K | 27.0% |
| Total | $8.05 avg | 64,498 |
| $519K |
| 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |